Cambridge Healthtech Institute’s Inaugural

Antibody-Drug Conjugates

August 13, 2025

Join us at Cambridge Healthtech Institute’s Inaugural Antibody-Drug Conjugates conference, where we explore cutting-edge innovations in ADC design and engineering, with a special focus on solid-tumor applications. This year’s event delves into the latest advancements in novel ADC targets, payloads, and linker technologies to enhance therapeutic efficacy and precision. We address critical challenges in ADC tolerability, resistance mechanisms, and toxicity, aiming to expand their therapeutic potential. Gain insights from the successes and shortcomings of ADC trials and explore opportunities to combine ADCs with other immuno-oncology therapies, driving progress toward safer and more effective treatments.

Who should attend:

- Biotech founders in IO
- Pharma directors
- Principal and senior scientists
- IO professors and post-docs
- Immunologists and oncologists
- Computational biologists
- Regulatory-affairs specialists
- Clinical-trial managers
- Those researching:

Antibody-drug conjugates
Antibodies
Cell therapy

Coverage will include, but is not limited to:

Session: Innovations in ADC Design and Engineering:

Novel ADC targets for both oncology and non-oncology indications
Novel payloads for enhanced efficacy
Advancements in linker technologies for improved therapeutic index

Cleavable and non-cleavable linker development for controlled drug release

Pros and cons of site-specific conjugation vs. stochastic conjugation

Session: Improving ADC Tolerability and Expanding Therapeutic Horizons:

Understanding and overcoming resistance mechanisms
Minimizing toxicity and adverse events
Improving ADCs’ capabilities against solid tumors
ADC combinations with other IO therapeutics

Lessons learned from successful and failed ADCs

The deadline for priority consideration is January 31, 2025.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation: